First Manhattan
KALA icon

First Manhattan’s KALA BIO KALA Stock Holding History

First Manhattan’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 1747
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1596
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1616
2022
Q1 		$2K Hold
1
– – ﹤0.01% 1483
2021
Q4 		$2K Hold
1
– – ﹤0.01% 1480
2021
Q3 		$4K Hold
1
– – ﹤0.01% 1433
2021
Q2 		$7K Buy
+1
New +$15.7K ﹤0.01% 1332
2020
Q2 		– Hold
0
– -$1K – 1430
2020
Q1 		– Sell
-190
Closed -$3.04M – 1337
2019
Q4 		$1.75M Buy
+190
New +$1.83M 0.01% 341

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan's KALA Position: Q4 2022 in Review

First Manhattan sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 1 share.

First Manhattan first reported a position in KALA in Q4 2019 and held it in 7 quarters. The position peaked at $1.75M in Q4 2019. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • First Manhattan reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • First Manhattan sold 1 KALA BIO share in Q4 2022.
  • First Manhattan first reported a position in KALA BIO in Q4 2019 and held it in 7 quarters.
  • First Manhattan's KALA BIO position peaked at $1.75M in Q4 2019.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.